Drug for improving prognosis for subarachnoid hemorrhage
    1.
    发明申请
    Drug for improving prognosis for subarachnoid hemorrhage 审中-公开
    用于改善蛛网膜下腔出血预后的药物

    公开(公告)号:US20060135607A1

    公开(公告)日:2006-06-22

    申请号:US10544480

    申请日:2004-02-02

    IPC分类号: A61K31/202 A61K31/22

    CPC分类号: A61K31/202 A61K31/232

    摘要: It is intended to provide a drug for improving prognosis for subarachnoid hemorrhage which contains, as the active ingredient, at least one member selected from the group consisting of eicosapentaenoic acid (EPA) and pharmaceutically acceptable salts and esters thereof, and a method of improving prognosis for subarachnoid hemorrhage which comprises orally or gastrically administering the above drug.

    摘要翻译: 旨在提供一种用于改善蛛网膜下腔出血预后的药物,其含有选自二十碳五烯酸(EPA)及其药学上可接受的盐和酯的至少一种作为活性成分,以及改善预后的方法 包括口服或胃内施用上述药物的蛛网膜下腔出血。